Sutent
Sunitinib malate · Pfizer Laboratories Div Pfizer Inc
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Sutent ingredients
| Active ingredient | Strength |
|---|---|
| Sunitinib Malate | 50 mg/1, 25 mg/1, 12.5 mg/1, 37.5 mg/1 |
What Sutent is used for
Sutent is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Sutent
- Generic name
- Sunitinib malate
- Made by
- Pfizer Laboratories Div Pfizer Inc
- Forms
- Capsule
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA021938
- On the US market since
- 2006
Official information
- Sutent prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Sunitinib malate)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Sutent?
Sutent (Sunitinib malate) is a cancer medicine made by Pfizer Laboratories Div Pfizer Inc, approved by the US FDA.
What are the ingredients of Sutent?
Sutent contains Sunitinib Malate (50 mg/1, 25 mg/1, 12.5 mg/1, 37.5 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA